On October 31, 2023, the Board of Directors of Exact Sciences Corporation expanded the size of the Board from 10 to 11 members and appointed Timothy Scannell as a Class III member of the Board with a term ending at the Company?s 2024 annual meeting of shareholders. In connection with his appointment to the Board, Mr. Scannell was also appointed to the Board?s Audit and Finance Committee. Mr. Scannell, age 59, brings over 30 years of experience and success delivering market-leading results from his leadership roles at Stryker Corporation.

Mr. Scannell served as President and Chief Operating Officer of Stryker between 2018 and 2021, overseeing all of Stryker?s commercial businesses and regions globally. Prior to this role, he served as group president for Stryker?s MedSurg & Neurotechnology businesses for ten years. He currently serves as a director and non-executive chairman of the board of directors for Insulet Corporation and is a member of the board of directors of Novocure Limited.

Mr. Scannell earned a bachelor?s degree in business administration and an MBA from the University of Notre Dame.